Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Z T Fidarova"'
Autor:
A V Bazhenov, G M Galstyan, E N Parovichnikova, V V Troitskaya, L A Kuzmina, Z T Fidarova, E O Gribanova, S A Makhinya, O A Latyshkevich, U A Chabaeva, S M Kulikov, V G Savchenko
Publikováno v:
Терапевтический архив, Vol 91, Iss 7, Pp 14-24 (2019)
Aim. Remission induction can be associate, with the life threatening complications and transfer to ICU of de novo acute myeloid leukemia (AML) patients (pts). We evaluate influence of transfer to ICU and life threatening complication on early mortali
Externí odkaz:
https://doaj.org/article/0f9fa6f9da044e4fb6fbb3950117b512
Autor:
E N PAROVICHNIKOVA, I A LOUKIANOVA, V V TROITSKAYA, M Y DROKOV, T I LOBAOVA, L A KUZMINA, A N SOKOLOV, A V KOKHNO, Z T FIDAROVA, G A BASKHAEVA, O A GAVRILINA, V A VASILYEVA, T N OBUKHOVA, S A KUZNETSOVA, A B SUDARIKOV, V N DVIRNIK, I V GALTSEVA, J O DAVIDIVA, S M KULIKOV, V G SAVCHENKO
Publikováno v:
Терапевтический архив, Vol 90, Iss 7, Pp 14-22 (2018)
Objective. To analyze treatment results of 172 patients with acute myeloid leukemia (AML) aged 18-60 years in National Medical Research Center for Hematology of MHRF. Materials and methods. Inductive and consolidation program for 139 (80%) patients w
Externí odkaz:
https://doaj.org/article/86c14a4b80d349a59c1c8acc0003408d
Autor:
V V Troitskaya, E N Parovichnikova, A N Sokolov, A V Kokhno, L A Kuzmina, D S Badmazhapova, Z T Fidarova, O A Gavrilina, A A Sidorova, G M Galstyan, S A Keselman, T V Gaponova, V S Galuzyak, S K Kravchenko, E O Gribanova, V G Savchenko
Publikováno v:
Терапевтический архив, Vol 87, Iss 7, Pp 33-40 (2015)
Aim. To evaluate the efficiency of the treatment policy for patients with acute myeloid leukemia (AML) and hyperleukocytosis (HL), which is aimed at preventing rapid hypercytolysis and massive tumor lysis (cytolysis) syndrome and/or at reducing the d
Externí odkaz:
https://doaj.org/article/8267e2799105405f9dace82189c90369
Autor:
E. A. Mikhaylova, Z. T. Fidarova, A. V. Abramova, A. V. Luchkin, V. V. Troitskaya, V. N. Dvirnyk, I. V. Galtseva, G. A. Kliasova, A. M. Kovrigina, S. M. Kulikov, Yu. А. Chabaeva, E. N. Parovichnikova, V. G. Savchenko, T. N. Obukhova
Publikováno v:
Терапевтический архив, Vol 92, Iss 7, Pp 4-9 (2020)
Treatment programs for patients with acquired aplastic anemia include two main therapeutic options: allogeneic bone marrow transplantation and combined immunosuppressive therapy (IST). However, combined IST remains the method of choice for most adult
Externí odkaz:
https://doaj.org/article/574dc4370279402b82bb06755b177aa5
Autor:
A. I. Dorofeeva, I. N. Shipunova, A. V. Luchkin, A. V. Abramova, Z. T. Fidarova, V. N. Dvirnyk, I. V. Galtseva, E. A. Mikhailova, E. N. Parovichnikova
Publikováno v:
Bulletin of Experimental Biology and Medicine. 174:538-543
Autor:
V. G. Savchenko, E. A. Lukina, E. A. Mikhaylova, N. V. Tsvetaeva, V. D. Latyshev, K. A. Lukina, Z. T. Fidarova, I. V. Galtseva, V. N. Dvirnik, V. V. Ptushkin, B. V. Afanasyev, A. D. Kulagin, E. R. Shilova, A. A. Maschan, N. S. Smetanina, S. A. Lugovskaya
Publikováno v:
Russian journal of hematology and transfusiology. 67:426-439
Introduction. Paroxysmal nocturnal hemoglobinuria (PNH) is a rare acquired clonal disease of the blood system characterized by intravascular hemolysis, bone marrow dysfunction and an increased risk of thrombotic and organ complications.Aim — to pro
Autor:
E. S. Kotova, O. A. Gavrilina, I. A. Yakutik, A. B. Sudarikov, Yu. A. Chabaeva, S. M. Kulikov, S. G. Beksaev, V. V. Troitskaya, G. A. Isinova, A. N. Sokolov, Z. T. Fidarova, I. A. Lukyanova, A. V. Abramova, V. N. Dvirnyk, I. V. Galtseva, T. N. Obukhova, E. N. Parovichnikova
Publikováno v:
Oncohematology. 17:98-107
Background. 6-mercaptopurine (6-MP) is a drug that is included in the treatment protocols for children and adults with acute lymphoblastic leukemias/lymphomas (ALL/LBL). It is known that individual differences in 6-MP tolerance can be explained by th
Autor:
E. A. Mikhailova, A. V. Luchkin, A. V. Abramova, Z. T. Fidarova, V. V. Troitskaya, V. N. Dvirnyk, I. V. Galtseva, A. M. Kovrigina, G. A. Alimova, T. N. Obukhova, T. V. Abramova, E. N. Parovichnikova, V. G. Savchenko
Publikováno v:
Russian journal of hematology and transfusiology. 67:29-40
Introduction. The use of thrombopoietin receptor agonists, especially eltrombopag, in the treatment of aplastic anemia (AA) patients who did not respond to the previous immunosuppressive therapy (IST), is accompanied by the development of a hematolog
Autor:
O. A. Gavrilina, G. M. Galstyan, A. E. Shchekina, E. S. Kotova, M. A. Maschan, V. V. Troitskaya, D. A. Koroleva, E. E. Zvonkov, Z. T. Fidarova, V. A. Vasilyeva, E. N. Parovichnikova
Publikováno v:
Russian journal of hematology and transfusiology. 67:8-28
Introduction. The introduction of chimeric antigen receptor (CAR) T-cell therapy is a promising treatment of patients with relapsed or refractory (R/R) B-cell lymphoproliferative diseases (LPDs).Aim — to present the results of CAR-T-cell therapy of
Autor:
A. I. Dorofeeva, I. N. Shipunova, N. I. Drize, A. V. Luchkin, A. V. Abramova, Z. T. Fidarova, V. N. Dvirnyk, I. V. Gal’tseva, E. A. Mikhailova, E. N. Parovichnikova
Publikováno v:
Bulletin of Experimental Biology and Medicine. 172:637-641